APORPHINE AND OXOAPORPHINE AND THE MEDICAL USE THEREOF

Details for Australian Patent Application No. 2003242227 (hide)

Owner LOTUS PHARMACEUTICAL CO., LTD.

Inventors SU, Mingjai; LEE, Shoeisheng

Agent A.P.T. Patent and Trade Mark Attorneys

Pub. Number AU-A-2003242227

PCT Number PCT/CN03/00477

PCT Pub. Number WO2004/110449

Filing date 19 June 2003

Wipo publication date 4 January 2005

International Classifications

A61K 031/473 - ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines

A61K 031/48 - Ergoline derivatives, e.g. lysergic acid, ergotamine

C07D 221/18 Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups

A61P 007/02 Drugs for disorders of the blood or the extracellular fluid

Event Publications

11 September 2003 Complete Application Filed

17 February 2005 Application Open to Public Inspection

  Published as AU-A-2003242227

10 April 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003242228-USER TERMINAL, SERVER, AND DATA PROVIDING METHOD

2003242226-LIQUID CONTAINER, CAP STRUCTURE USED THEREFOR, AND CAP COVER